Determining the Incidence of Drug-Associated Acute Kidney Injury in Nursing Home Residents

Journal of the American Medical Directors Association

Volumn 15, Issue 10, 2014, Pages 719-724

  Handler, Steven M ^a,b   Cheung, Pui Wen ^a   Culley, Colleen M ^b   Perera, Subashan ^a,b   Kane Gill, Sandra L ^a,b   Kellum, John A ^a   Marcum, Zachary A ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Acute kidney injury; Adverse drug events; Clinical decision support systems; Nursing homes

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIBIOTIC AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ACUTE KIDNEY FAILURE; AGED; ALARM MONITOR; ARTICLE; AUTOMATION; COMPUTER PROGRAM; CREATININE BLOOD LEVEL; DECISION SUPPORT SYSTEM; DRUG ASSOCIATED ACUTE KIDNEY INJURY; DRUG INDUCED DISEASE; DRUG SURVEILLANCE PROGRAM; FEMALE; HUMAN; INCIDENCE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NURSING HOME; NURSING HOME PATIENT; RETROSPECTIVE STUDY; RISK ASSESSMENT; UNITED STATES; ACUTE KIDNEY INJURY; BLOOD; CHEMICALLY INDUCED; HEALTH SURVEY; RISK FACTOR;

ACUTE KIDNEY INJURY; AGED; CREATININE; FEMALE; HUMANS; INCIDENCE; MALE; NURSING HOMES; PENNSYLVANIA; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; RISK FACTORS; SOFTWARE;

EID: 84927695650     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2014.03.014     Document Type: Article

References (45)

1. Abdel-Kader K., Palevsky P.M. Acute kidney injury in the elderly. Clin Geriatr Med 2009, 25:331-358.
2. Lameire N., Van Biesen W., Vanholder R. Acute renal failure. Lancet 2005, 365:417-430.
3. Bellomo R., Ronco C., Kellum J.A., et al. Acute renal failure: Definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004, 8:R204-R212.
4. Ricci Z., Cruz D., Ronco C. The RIFLE criteria and mortality in acute kidney injury: A systematic review. Kidney Int 2008, 73:538-546.
5. Uchino S., Bellommo R., Goldsmith D., et al. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med 2006, 34:1913-1917.
6. Hoste E.A., Clermont G., Kersten A., et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: A cohort analysis. Crit Care 2006, 10:R73.
7. Abosaif N.J., Tolba Y.A., Heap M., et al. The outcome of acute renal failure in the intensive care unit according to RIFLE: Model application, sensitivity and predictability. Am J Kidney Dis 2005, 46:1038-1048.
8. Cruz D.N., Bolgan I., Perazella M.A., et al. North East Italian prospective hospitalrenal outcome survey on acute kidney injury (NEiPHROS-AKI). Targeting the problem with the RIFLE criteria. Clin J Am Soc Nephrol 2007, 2:418-425.
9. Ali T., Khan I., Simpson W., et al. Incidence and outcomes in acute kidney injury: A comprehensive population-based study. JAm Soc Nephrol 2007, 18:1292-1298.
10. Dasta J.F., Kane-Gill S.L., Durtschi A.J., et al. Costs and outcomes of acute kidney injury (AKI) following cardiac surgery. Nephrol Dial Transplant 2008, 23:1970-1974.
11. Schiffl H., Fischer R. Five-year outcomes of severe acute kidney injury requiring renal replacement therapy. Nephrol Dial Transplant 2008, 23:2235-2241.
12. Hobson C.E., Yavas S., Segal M.S., et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation 2009, 119:2444-2453.
13. Hsu C.Y., Ordonez J.D., Chertow G.M., et al. The risk of acute renal failure in patients with chronic kidney disease. Kidney Int 2008, 74:101-107.
14. McClellan W.M., Resnick B., Lei L., et al. Prevalence and severity of chronic kidney disease and anemia in the nursing home population. JAm Med Dir Assoc 2010, 11:33-41.
15. Rosner M.H. Acute kidney injury in the elderly. Clin Geriatr Med 2013, 29:565-578.
16. ClinicalTrials.gov. Enhancing the detection and management of adverse drug events in nursing homes. Available at: . Accessed March 18,2014. http://clinicaltrials.gov/ct2/show/NCT01531088.
17. Gaiao S., Cruz D.N. Baseline creatinine to define acute kidney injury: Is there any consensus?. Nephrol Dial Transplant 2010, 25:3812-3814.
18. Lafrance J.P., Miller D.R. Defining acute kidney injury in database studies: The effects of varying the baseline kidney function assessment period and considering CKD status. Am J Kidney Dis 2010, 56:651-660.
19. Ostermann M., Chang R.W. Challenges of defining acute kidney injury. QJM 2011, 104:237-243.
20. Hanlon J.T., Aspinall S.L., Semla T.P., et al. Consensus guidelines for oral dosing of primarily renally cleared medictions in older adults. JAm Geriatr Soc 2009, 57:335-340.
21. Marcum Z.A., Arbogast K.L., Behrens M.C., et al. Utility of an adverse drug event trigger tool in Veterans Affairs nursing facilities. Consult Pharm 2013, 28:99-109.
22. Rind D.M., Safran C., Phillips R.S., et al. Effect of computer-based alerts on the treatment and outcomes of hospitalized patients. Arch Intern Med 1994, 154:1511-1517.
23. Jensen J.U., Hein L., Lundgren B., et al. Kidney failure related to broad-spectrum antibiotics in critically ill patients: Secondary end point results from a 12000 patient randomized trial. BMJ Open 2012, 2:e000635.
24. Goldstein S.L., Kirkendall E., Nguyen H., et al. Electronic health record identification of nephrotoxin exposure and associated acute kidney injury. Pediatrics 2013, 132:e756-e767.
25. Gurwitz J.H., Field T.S., Rochon P., et al. Effect of computerized provider order entry with clinical decision support on adverse drug events in the long-term care setting. JAm Geriatr Soc 2008, 56:2225-2233.
26. Selby N.M., Crowley L., Fluck R.J., et al. Use of electronic results reporting to diagnose and monitor AKI in hospitalized patients. Clin J Am Soc Nephrol 2012, 7:533-540.
27. Dishart M.K., Kellum J.A. An evaluation of pharmacological strategies for the prevention and treatment of acute renal failure. Drugs 2000, 59:79-91.
28. KDIGO clinical practice guideline for acute kidney injury. Available at: . Accessed January 21,2014. http://www.kdigo.org/clinical_practice:guidelines/pdf/KDIGO%20AKI%20Guideline.pdf.
29. Kane-Gill S.L., Kirisci L., Verrico M.M., Rothschild J.M. Analysis of risk factors for adverse drug events in critically ill patients. Crit Care Med 2012, 40:823-828.
30. van Kraaij D.J., Jansen R.W., Gribnau F.W., Hoefnagels W.H. Diuretic therapy in elderly heart failure patients with and without left ventricular systolic dysfunction. Drugs Aging 2000, 16:289-300.
31. Anthes A.M., Harinstein L.M., Smithburger P.L., et al. Improving adverse drug event detection in critically ill patients through screening intensive care unit transfer summaries. Pharmacoepidemiol Drug Saf 2013, 22:510-516.
32. Marcum Z.A., Amuan M.E., Hanlon J.T., et al. Prevalence of unplanned hospitalizations caused by adverse drug reactions among older veterans. JAm Geriatr Soc 2012, 60:34-41.
33. Office of Inspector General. Medicare nursing home resident hospitalization rates merit additional monitoring. Available at: . Accessed January 21,2014. http://https://oig.hhs.gov/oei/reports/oei-06%1311%1300040.pdf.
34. Walsh EG, Freiman M, Haber S, etal. Cost drivers for dually eligible beneficiaries: Potentially avoidable hospitalizations from nursing facility, skilled nursing facility, and home and community-based services waiver programs. Final task 2 report. Available at: . Accessed January 21,2014. http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Reports/downloads/costdriverstask2.pdf.
35. Murugan R., Kellum J.A. Acute kidney injury: What's the prognosis?. Nat Rev Nephrol 2011, 7:209-217.
36. Handler S.M., Shirts B.H., Perera S., et al. Frequency of laboratory monitoring of chronic medications administered to nursing facility residents: Resultsof a national Internet-based study. Consult Pharm 2008, 23:387-395.
37. Steinman M.A., Handler S.M., Gurwitz J.H., et al. Beyond the prescription: Medication monitoring and adverse drug events in older adults. JAm Geriatr Soc 2011, 59:1513-1520.
38. Institute of Medicine. Patient Safety: Achieving a New Standard for Care 2004, The National Academies Press, Washington, DC. P. Aspden, J. Corrigan, J. Wolcott, S. Erickson (Eds.).
39. Institute of Medicine. Preventing Medication Errors 2007, National Academies Press, Washington, DC. P. Aspden, J. Wolcott, J.L. Bootman, L.R. Cronenwett (Eds.).
40. National Quality Forum. Safe practices for better healthcare: A consensus report. Available at: . Accessed January 21,2014. http://www.ahrq.gov/professionals/quality-patient-safety/patient-safety-resources/resources/nqfpract.pdf.
41. Shojania K.G., Duncan B.W., McDonald K.M., et al. Making health care safer: A critical analysis of patient safety practices. Evid Rep Technol Assess (Summ) 2001, 1-668. i-x.
42. Bain K.T. Adverse drug reactions and current state of drug regimen review innursing facilities: Need for a change?. Consult Pharm 2007, 22:586-592.
43. Martin C.M., McSpadden C.S. Changes in the state operations manual: Implications for consultant pharmacy practice. Consult Pharm 2006, 21:948-961.
44. US Department of Health and Human Services and Centers for Medicare and Medicaid Services. Guidance to surveyors for long term care facilities. Available at: . Accessed January 21,2014. http://www.cms.hhs.gov/transmittals/downloads/R22SOMA.pdf.
45. Mehta R.L., Kellum J.A., Shah S.V., et al. Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007, 11:R31.